Curida is a trusted partner committed to improving lives through their wide range of products and services. As a leading pharmaceutical development and manufacturing company, they specialize in the development and manufacture of medicines that ensure a safe supply of life-improving products. They offer small molecules formulations, liquid pharmaceuticals based on sterile blow-fill-seal technology, and nasal spray products.

Their expertise also extends to sterile and aseptic development and fill & finish processes. In addition, Curida acquired Diatec in 2022, enabling them to provide specialized services in monoclonal antibodies production and conjugation. Their commitment to quality is evident in all their offerings, as they work with controlled substances and biologics to deliver the best healthcare solutions.

Curida further serves Norwegian pharmacies by providing raw materials from Curida Elverum and liquid products from Ås produksjonslab. They take responsibility seriously and prioritize responsible business practices. Partnering with Curida means gaining the freedom, support, and opportunities to advance your career.

Stay updated with their latest news and events, including their recent CEO appointment and the acquisition of Diatec. Contact Curida today to learn more about their pharmaceutical development and manufacturing solutions. They look forward to discussing your next project and serving a wide range of customers, from academic research to big pharmaceutical companies